FDA Chief Medical Officer and Center for Biologics Evaluation and Research Director Vinay Prasad has called for the agency to reflect following reports that children's deaths are linked to the COVID-19 vaccine.
Tylenol manufacturer Kenvue Brands LLC sent a letter to the Food and Drug Administration, criticizing demands that the drug's label be changed to reflect greater safety warnings.
The FDA announced the first round of pharmaceuticals that will receive expedited reviews under the Commissioner’s National Priority Voucher (CNPV) pilot program.
The Food and Drug Administration (FDA) announced that it has initiated the process of changing the labeling for Tylenol in light of President Trump's announcement that acetaminophen is linked to autism development when used during pregnancy.